跳至主要内容
临床试验/IRCT2012072910230N2
IRCT2012072910230N2已完成2 期

Mesalamine effects on mucosal immune biomarkers in irritable bowel syndrome with diarrhea-predominant symptoms

Digestive and Liver Disease Research Center, Shariati Hospital0 个研究点目标入组 58 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 90 years(—)
性别
All

入选标准

  • 1- Consent to participate in the study and signing the consent form; 2 - being at the age of 18 years and older. Exclusion criteria: 1 - Pregnancy or breast feeding; 2 - not using appropriate contraceptive methods; 3 - the use of NSAIDs; 4 - Use of corticosteroids, antibiotics, mast cell stabilizing drugs; 5- Large abdominal surgery; 6 - Celiac disease (positive Anti TTG and Anti Endomysial Ab); 7 - specific allergic diseases like asthma (positive family and personal history and positive Anti IGE); 8 - organic or psychological disorders characterized by history and specific laboratory tests; 9 - lack of cooperation in implementation of the Study.

排除标准

  • 未提供

研究者

发起方
Digestive and Liver Disease Research Center, Shariati Hospital

相似试验

Mesalamine effects on mucosal immune biomarkers in... | 临床试验